Oric Pharmaceuticals: director Richard A. Heyman sold 6,700 shares

What happened

• Richard A. Heyman, director, exercised options for 3,500 shares at $1.60 on Oct 1, 2026 (cost $5,600) and a separate exercise/conversion of 3,500 shares is reported at $0.00. He sold 3,500 shares at $12.91 ($45,199) and 3,200 shares at $12.91 ($41,325) on Oct 1, 2026, total sale $86,524.

Key details

• Transaction date: Oct 1, 2026. Form filed Oct 2, 2026.
• Reported sale price: $12.91 per share for each sale line; footnote reports multiple trades at prices ranging from $12.57 to $13.39.
• Exercise price paid: $1.60 per share for the 3,500-share exercise (total $5,600); one exercise/conversion reported at $0.00.
• Shares owned after the transaction: not specified in the filing; shares are held of record by RAHD Capital, LLC and the reporting person has voting and investment power with respect to such shares.
• Footnotes of note:
  • F1: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and RAHD Capital, LLC.
  • F2: Sales executed in multiple trades at prices ranging from $12.57 to $13.39; reporting person can provide breakdown on request.
  • F3: Shares are held of record by RAHD Capital, LLC; reporting person has voting and investment power.
  • F4: Shares subject to the option are fully vested and immediately exercisable.

Why it may matter

• The filing shows option exercises on Oct 1, 2026 and same-day open-market sales; the timing is consistent with a cashless exercise/sale pattern reported in the Form 4.
• A filing does not show why the insider traded or why the company acted.